Pancoast tumor screening

Pancoast tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pancoast tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pancoast tumor screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pancoast tumor screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pancoast tumor screening
CDC onPancoast tumor screening
Pancoast tumor screening in the news
Blogs on Pancoast tumor screening
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Pancoast tumor screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

There is insufficient evidence to recommend routine screening for Pancoast tumor.

Screening

• There is insufficient evidence to recommend routine screening for Pancoast tumor.
• The current guidelines for screening of lung cancer that results in pancoast tumor is as follows:
  • In 2013, a clinical practice guideline by the U.S. Preventive Services Task Force (USPSTF) recommended screening for lung cancer among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation).
  • Clinical practice guidelines issued by the American College of Chest Physicians in 2013 recommend:
    • For smokers and former smokers who are age 55 to 74 and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years, it was suggest that annual screening with low dose computed tomography (LDCT) should be offered in settings that can deliver the comprehensive care provided to National Lung Screening Trial (NLST) participants.